CG
RXST icon

Caprock Group’s RxSight RXST Stock Holding History

Caprock Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.6K Hold
18,803
– – ﹤0.01% 1207
2026
Q1 		$116K Sell
18,803
-2,444
-12% -$20.3K ﹤0.01% 1074
2025
Q4 		$221K Buy
21,247
+2,286
+12% +$22.9K ﹤0.01% 1087
2025
Q3 		$171K Buy
+18,961
New +$166K ﹤0.01% 1077
2025
Q1 		$479K Hold
18,961
– – 0.01% 737
2024
Q4 		$652K Hold
18,961
– – 0.02% 539
2024
Q3 		$937K Sell
18,961
-32
-0.2% -$1.64K 0.03% 404
2024
Q2 		$1.14M Buy
+18,993
New +$1.09M 0.05% 334

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caprock Group's RXST Position: Q2 2026 in Review

Caprock Group held its RxSight (RXST) position steady in Q2 2026 at 18,803 shares worth $90.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1207.

Caprock Group first reported a position in RXST in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.14M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Caprock Group held 18,803 shares of RxSight worth $90.6K as of Q2 2026.
  • Caprock Group left its RxSight share count unchanged in Q2 2026.
  • RxSight made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1207 holding.
  • Caprock Group first reported a position in RxSight in Q2 2024 and has held it in 8 quarters since.
  • Caprock Group's RxSight position peaked at $1.14M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.